RecruitingNot ApplicableNCT05922553

Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

The Effectiveness of Mukbang in Helping Children With Cancer Hospitalized for Radiotherapy and Chemotherapy to Improve Appetite, Nutritional Status and Quality of Life: A Randomized Control Trial

Sponsor

Wei XIA, PhD

Enrollment

124 participants

Start Date

Dec 16, 2024

Study Type

INTERVENTIONAL

Conditions

Children With Cancer

Summary

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Eligibility

Min Age: 6 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Active Ingredient Mukbang and a behavioral approach called General short videos for people with children with cancer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALActive Ingredient Mukbang

Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.

BEHAVIORALGeneral short videos

Short videos that don't contain any food cues.

Locations(1)

Sun Yat-sen Memorial Hospital

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05922553

Related Trials

Evaluation of the Effect of a Physical Activity Recovery Stay

NCT063204961 location